Inovio Pharmaceuticals (INO) Short Interest Ratio & Short Volume → get a piece of the profit from this land (From True Market Insiders) (Ad) Free INO Stock Alerts $12.00 -0.79 (-6.18%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Inovio Pharmaceuticals Short Interest DataCurrent Short Volume2,030,000 sharesPrevious Short Volume2,260,000 sharesChange Vs. Previous Month-10.18%Dollar Volume Sold Short$23.24 millionShort Interest Ratio / Days to Cover4.4Last Record DateApril 30, 2024Outstanding Shares25,910,000 sharesFloat Size25,710,000 sharesShort Percent of Float7.90%Today's Trading Volume414,844 sharesAverage Trading Volume299,380 sharesToday's Volume Vs. Average139% Short Selling Inovio Pharmaceuticals ? Sign up to receive the latest short interest report for Inovio Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINO Short Interest Over TimeINO Days to Cover Over TimeINO Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Inovio Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,030,000 shares $23.24 million -10.2%7.9%4.4 $11.45 4/15/20242,260,000 shares $24.84 million +7.6%8.9%4.6 $10.99 3/31/20242,100,000 shares $29.15 million +1.9%9.1%3.9 $13.88 3/15/20242,060,000 shares $22.10 million +10.8%9.0%3.9 $10.73 2/29/20241,860,000 shares $16.48 million +6.9%8.1%3.9 $8.86 2/15/20241,740,000 shares $12.95 million +21.7%7.8%4.4 $7.44 Get the Latest News and Ratings for INO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inovio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,430,000 shares $7.71 million -23.9%6.4%4.2 $5.39 1/15/202422,510,000 shares $207.99 million -5.8%N/A6.3 $9.24 12/31/202323,890,000 shares $12.18 million -1.6%N/A5.5 $0.51 12/15/202324,270,000 shares $9.44 million -5.7%N/A7 $0.39 11/30/202325,730,000 shares $10.14 million -0.9%N/A7.5 $0.39 11/15/202325,950,000 shares $9.87 million +4.1%N/A7.6 $0.38 10/31/202324,940,000 shares $9.09 million -3.0%N/A7.3 $0.36 10/15/202325,710,000 shares $13.18 million +72.6%N/A7.4 $0.51 9/30/202314,900,000 shares $5.80 million -4.7%N/A4.7 $0.39 9/15/202315,630,000 shares $6.25 million -6.4%N/A3.6 $0.40 8/31/202316,700,000 shares $7.51 million -24.3%N/A2.5 $0.45 8/15/202322,060,000 shares $9.93 million +2.2%N/A2.8 $0.45 7/31/202321,580,000 shares $11.48 million +3.2%N/A2.5 $0.53 7/15/202320,920,000 shares $10.98 million -13.2%N/A2.3 $0.53 6/30/202324,110,000 shares $10.77 million -45.0%N/A2.5 $0.45 6/15/202343,830,000 shares $22.18 million +2.5%N/A4.7 $0.51 5/31/202342,780,000 shares $25.61 million +9.0%N/A6.4 $0.60 5/15/202339,250,000 shares $30.13 million -0.7%N/A6.8 $0.77 4/30/202339,510,000 shares $30.52 million -0.4%N/A7.7 $0.77 4/15/202339,650,000 shares $33.81 million +13.9%N/A7.5 $0.85 3/31/202334,820,000 shares $28.55 million -11.9%N/A7 $0.82 3/15/202339,520,000 shares $45.45 million -1.8%N/A8.8 $1.15 2/28/202340,260,000 shares $50.73 million -0.4%N/A8.5 $1.26 2/15/202340,410,000 shares $62.64 million -7.6%N/A8.3 $1.55 1/31/202343,740,000 shares $72.61 million -2.3%N/A7.9 $1.66 1/15/202344,790,000 shares $85.10 million +0.1%N/A7.9 $1.90 12/30/202244,760,000 shares $69.83 million -0.5%N/A7.9 $1.56 12/15/202244,990,000 shares $79.18 million +4.0%N/A7.9 $1.76 11/30/202243,270,000 shares $88.27 million -6.2%N/A7.4 $2.04 11/15/202246,150,000 shares $115.38 million +5.7%N/A7.9 $2.50 10/31/202243,670,000 shares $94.33 million -4.2%N/A7.6 $2.16 10/15/202245,570,000 shares $71.09 million +1.5%N/A8.1 $1.56 9/30/202244,920,000 shares $77.49 million -1.8%N/A7.9 $1.73 9/15/202245,730,000 shares $96.03 million +0.3%N/A7.7 $2.10Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. INO Short Interest - Frequently Asked Questions What is Inovio Pharmaceuticals' current short interest? Short interest is the volume of Inovio Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 2,030,000 shares of INO short. 7.90% of Inovio Pharmaceuticals' shares are currently sold short. Learn More on Inovio Pharmaceuticals' current short interest. What is a good short interest ratio for Inovio Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INO shares currently have a short interest ratio of 4.0. Learn More on Inovio Pharmaceuticals's short interest ratio. Which institutional investors are shorting Inovio Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Inovio Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Inovio Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.90% of Inovio Pharmaceuticals' floating shares are currently sold short. Is Inovio Pharmaceuticals' short interest increasing or decreasing? Inovio Pharmaceuticals saw a decrease in short interest in April. As of April 30th, there was short interest totaling 2,030,000 shares, a decrease of 10.2% from the previous total of 2,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Inovio Pharmaceuticals' float size? Inovio Pharmaceuticals currently has issued a total of 25,911,000 shares. Some of Inovio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Inovio Pharmaceuticals currently has a public float of 25,710,000 shares. How does Inovio Pharmaceuticals' short interest compare to its competitors? 7.90% of Inovio Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Inovio Pharmaceuticals: Sight Sciences, Inc. (5.18%), TriSalus Life Sciences, Inc. (7.13%), AngioDynamics, Inc. (5.37%), Utah Medical Products, Inc. (2.56%), NeuroPace, Inc. (0.65%), AVITA Medical, Inc. (6.69%), Treace Medical Concepts, Inc. (6.73%), Tactile Systems Technology, Inc. (5.64%), Profound Medical Corp. (1.27%), Delcath Systems, Inc. (3.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Inovio Pharmaceuticals stock? Short selling INO is an investing strategy that aims to generate trading profit from Inovio Pharmaceuticals as its price is falling. INO shares are trading down $0.79 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inovio Pharmaceuticals? A short squeeze for Inovio Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INO, which in turn drives the price of the stock up even further. How often is Inovio Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SGHT Short Interest Data TLSI Short Interest Data ANGO Short Interest Data UTMD Short Interest Data NPCE Short Interest Data RCEL Short Interest Data TMCI Short Interest Data TCMD Short Interest Data PROF Short Interest Data DCTH Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research